{
    "clinical_study": {
        "@rank": "107677", 
        "arm_group": [
            {
                "arm_group_label": "MTA/FS pulpotomy", 
                "arm_group_type": "Experimental", 
                "description": "Children randomized to this arm will undergo a mineral trioxide aggregate (MTA) pulpotomy after hemostasis is achieved using ferric sulfate (FS)."
            }, 
            {
                "arm_group_label": "RCT/ZOE", 
                "arm_group_type": "Active Comparator", 
                "description": "Children randomized to this group will undergo the root canal/zinc oxide and eugenol (RCT/ZOE) technique."
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this investigation is to compare the clinical and radiographic outcomes of\n      pulpotomies done using mineral trioxide aggregate (MTA) dental cement and the root\n      canal/zinc oxide and eugenol (RCT/ZOE) technique in primary maxillary incisors."
        }, 
        "brief_title": "Mineral Trioxide Aggregate Pulpotomy in Primary Maxillary Incisors", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Dental Caries", 
            "Dental Pulp Exposure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Dental Caries", 
                "Dental Pulp Exposure"
            ]
        }, 
        "detailed_description": {
            "textblock": "The primary maxillary incisors are important in masticatory function, occlusal development,\n      articulation and self-esteem.  Cariously exposed vital pulps of primary incisors require\n      pulp treatment to avoid infection, pain and premature tooth loss.  Unfortunately, there is a\n      paucity of investigations of maxillary incisor pulp treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  children with one or more carious primary maxillary incisors where removal of dental\n             caries will likely to produce a vital pulp exposure\n\n          -  reside in the GTA at time of inclusion\n\n          -  English-speaking\n\n        Exclusion Criteria:\n\n          -  clinical or radiographic evidence of pulp degeneration (such as internal/external\n             root resorption and/or periapical bone destruction or swelling)\n\n          -  radiographic evidence of physiological root resorption\n\n          -  possibility of proper restoration of the tooth\n\n          -  maxillary incisors present with an associated swelling"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02019563", 
            "org_study_id": "1000019443"
        }, 
        "intervention": [
            {
                "arm_group_label": "RCT/ZOE", 
                "description": "After complete removal of all caries, if a pulp exposure is detected the pulp chamber will be opened and the pulp tissue removed. The canal will be irrigated with water and then filled with non-reinforced ZOE.", 
                "intervention_name": "Root canal/zinc oxide and eugenol (RCT/ZOE) technique", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "MTA/FS pulpotomy", 
                "description": "After complete removal of all caries, if a pulp exposure is detected the pulp chamber will be opened and vital coronal pulp to a depth of 2mm below free gingival margin will be removed. A solution of ferric sulfate will be applied to the amputated pulp surface and then flushed with water. MTA paste is then used to cover over the exposed amputated pulp surface.", 
                "intervention_name": "Mineral trioxide aggregate/ferric sulfate (MTA/FS) pulpotomy", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Eugenol", 
                "Zinc Oxide", 
                "Ferric Compounds"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pediatrics", 
            "dental caries", 
            "dental pulp exposure", 
            "incisor"
        ], 
        "lastchanged_date": "April 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5G 1X8"
                }, 
                "name": "The Hospital for Sick Children"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective Outcome Investigation of Mineral Trioxide Aggregate Pulpotomy in Primary Maxillary Incisors", 
        "overall_official": {
            "affiliation": "The Hospital for Sick Children, Toronto Canada", 
            "last_name": "Peter Judd, DDS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Incisor Survival", 
                "safety_issue": "No", 
                "time_frame": "1 year after the procedure"
            }, 
            {
                "measure": "Incisor Survival", 
                "safety_issue": "No", 
                "time_frame": "2 years after the procedure"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02019563"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Hospital for Sick Children", 
            "investigator_full_name": "Peter Judd", 
            "investigator_title": "Dentist-in-Chief", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Presence of a number of clearly defined radiographic and clinical signs", 
            "safety_issue": "No", 
            "time_frame": "At 1 and 2 years after the procedure"
        }, 
        "source": "The Hospital for Sick Children", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Hospital for Sick Children", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}